Tim Shaw

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

Jonathan Edwards, L Szczepański, Jacek Szechiński et al. · New England Journal of Medicine · 2004 · 2.6K citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

Gerd R Burmester, Stanley Cohen, Kevin Winthrop et al. · RMD Open · 2023 · 210 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Rituximab Pharmacokinetics in Patients With Rheumatoid Arthritis: B‐Cell Levels Do Not Correlate With Clinical Response

Ferdinand C. Breedveld, Sunil Agarwal, Ming Yin et al. · The Journal of Clinical Pharmacology · 2007 · 147 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +16

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE

Paul P. Tak, William F. C. Rigby, Andrea Rubbert‐Roth et al. · Annals of the Rheumatic Diseases · 2011 · 108 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate

Stanley Cohen, Edward Keystone, Mark C. Genovese et al. · Annals of the Rheumatic Diseases · 2010 · 100 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14